on Onco-Innovations Limited (isin : CA68237C1059)
Onco-Innovations to List Shares on Cboe Canada
Onco-Innovations Limited has announced the transfer of its common shares listing to Cboe Canada from the Canadian Securities Exchange (CSE). Trading is set to commence on May 22, 2025, under the ticker "ONCO." The voluntary delisting from the CSE is expected at the close on May 21, 2025. Shareholders need not take action during this transition.
Cboe Canada provides a reputable platform as part of the Cboe Markets network. It supports companies with notable market infrastructure and data solutions. This strategic move aligns with Onco-Innovations' goals of visibility and investor engagement in the oncology sector.
CEO Thomas O'Shaughnessy stated that this step will enhance engagement and broaden the investor base, aligning financial strategies with scientific goals.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Onco-Innovations Limited news